Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9

Area of Science:

• Molecular Biology
• Developmental Biology
• Genetics

Background:

• Myogenic regulatory factors (MRFs) like Myod1 are essential for muscle development.
• Myogenin is a key MRF, and its absence causes severe defects in mice without compensation.
• The role of MYOGENIN in human myogenesis and potential compensatory mechanisms remains unclear.

Purpose of the Study:

• To investigate the function of MYOGENIN in human myogenic cells.
• To determine if MYOD1 or other factors can compensate for MYOGENIN loss in humans.
• To elucidate the regulatory mechanisms of skeletal muscle differentiation and formation.

Main Methods:

• CRISPR/Cas9 genome editing was used to create MYOGENIN-mutated human induced pluripotent stem cells (iPSCs).
• Skeletal muscle differentiation was induced and analyzed in the generated cell lines.

Main Results:

• MYOGENIN-mutated human iPSCs retained the capacity for skeletal muscle differentiation.
• Evidence suggests that MYOD1-independent or MYOD1-dependent mechanisms can compensate for the absence of MYOGENIN.
• These compensatory pathways are vital for regulating human skeletal muscle formation.

Conclusions:

• MYOGENIN is not solely essential for human skeletal muscle differentiation, unlike in mice.
• Human iPSCs demonstrate plasticity in myogenic regulatory factor function.
• Compensatory mechanisms involving MYOD1 are critical for robust skeletal muscle development in humans.